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The anaphase promoting complex or cyclosome (APC/C) is a large multi-
subunit E3 ubiquitin ligase that orchestrates cell cycle progression bymediating
the degradation of important cell cycle regulators. During the two decades
since its discovery, much has been learnt concerning its role in recognizing
and ubiquitinating specific proteins in a cell-cycle-dependent manner, the
mechanisms governing substrate specificity, the catalytic process of assembling
polyubiquitin chains on its target proteins, and its regulation by phos-
phorylation and the spindle assembly checkpoint. The past few years have
witnessed significant progress in understanding the quantitative mechanisms
underlying these varied APC/C functions. This review integrates the overall
functions and properties of the APC/C with mechanistic insights gained
from recent cryo-electron microscopy (cryo-EM) studies of reconstituted
human APC/C complexes.1. The anaphase promoting complex or cyclosome
regulates cell cycle transitions
The anaphase promoting complex or cyclosome (APC/C) is a multi-subunit
cullin-RING E3 ubiquitin ligase that functions to regulate progression through
the mitotic phase of the cell cycle and to control entry into S phase [1–4]. The
APC/C also plays a role in regulating meiosis, and has been implicated in post-
mitotic functions including dendrite formation in neurons, as well as metabolic,
learning and memory processes [5–10]. APC/C-mediated coordination of cell
cycle progression is achieved through the temporal and spatial regulation of
APC/C activity and substrate specificity. The APC/C becomes activated at the
onset of mitosis, and ubiquitinates Nek2A and cyclin A (an S- and M-phase
cyclin) at prometaphase. At metaphase, the APC/C targets for degradation two
inhibitors of the anaphase transition, namely, securin and cyclin B (M-phase
cyclin) [11,12]. Securin is a protein inhibitor of separase, a protease that cleaves
the cohesin subunit kleisin [13]. Cleavage of kleisin disassembles cohesin to trig-
ger sister chromatid segregation and the onset of anaphase [14–16], reviewed in
Nasmyth [17]. Reduced cyclin B levels are also required for entry into anaphase,
since Cdk1 (cyclin-dependent kinase 1)-cyclin B1 inhibits separase [18–20]. After
anaphase, cyclin destruction continues to maintain negligible Cdk activity,
necessary for the cell to disassemble the mitotic spindle and exit mitosis
[12,21–25]. DuringG1, themain role of theAPC/C is to sustain low levels ofmito-
tic Cdk activity to allow for resetting of replication origins as a prelude to a new
round of DNA replication in S phase [26,27].
The temporal regulation of APC/C activity is achieved through a combination
of two structurally related coactivator subunits, Cdc20 andCdh1 [28–38], coupled
to protein phosphorylation, APC/C inhibitors and differential affinity for APC/C
substrates. The two APC/C coactivators have opposing activity profiles. Cdc20
activates the APC/C during early mitosis when the APC/C is phosphorylated
and Cdh1 activity is low due to its Cdk-dependent phosphorylation, whereas
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2APC/C
Cdc20-mediated reduction of Cdk activity stimulates
Cdh1. In turn, APC/CCdh1 ubiquitinates Cdc20, leading to
APC/CCdc20 inactivation (with Cdc20 auto-ubiquitination
also playing a role [39]). Thus, Cdc20 activates Cdh1 that in
turn antagonizes Cdc20 activity. The switching between
APC/CCdc20 and APC/CCdh1 fulfils two main functions. First,
APC/CCdc20 and APC/CCdh1 have over-lapping but never-
theless distinct substrate specificities. Therefore, specific cell
cycle regulators are degraded during the separate phases of
APC/CCdc20 and APC/CCdh1 activity, allowing for ordered
progression through the cell cycle. Second, Cdc20 and Cdh1
are subject to control by different regulatory mechanisms.
Cdc20 activates the APC/C that is phosphorylated by Cdk
and Plk1 protein kinases during early mitosis, whereas Cdh1
is inhibited by its Cdk-mediated phosphorylation. Importantly,
APC/CCdc20 activity towards securin and cyclin B is inhibited
by the mitotic checkpoint complex (MCC), a multi-protein
complex activated by the spindle assembly checkpoint (SAC),
reviewed in Lara-Gonzalez et al. [40] and Musacchio [41]. The
SAC ensures that anaphase is delayed until every chromosome
is aligned on themitotic spindle. Emi1 inhibitsmetazoanAPC/
CCdh1 during interphase [42–44], whereas Acm1 inhibits
Saccharomyces cerevisiae APC/CCdh1 [45,46]. The structurally
related protein Emi2 (XErp1) regulates the APC/C in
embryonic cells and meiosis [47].2. The APC/C is a multi-subunit cullin-RING
E3 ligase
The large size and complex architecture of the APC/C is inti-
mately linked to its regulatory mechanisms involving control
by reversible phosphorylation, the SAC, Emi1 and inter-
changeable coactivator subunits. These regulatory
mechanisms ensure the APC/C is controlled in a cell-cycle-
dependent manner and that its substrate specificity is also
modulated throughout the cell cycle.
Subunit composition.TheAPC/Ccomprises the core complex
(14 subunits inmetazoans, 13 inyeast) [48–59], togetherwith the
interchangeable coactivator subunits (either Cdc20 or Cdh1)
[28,29,31] (table 1). APC/C subunits are functionally and
structurally organized into three classes: the catalytic module,
the substrate recognition module and the scaffolding module
(table 1). The catalytic module comprises Apc11, the RING
domain subunit [61–63] and Apc2, the cullin subunit
[50,51,63]. These two subunits are orthologues of Rbx1 and the
cullin subunit of cullin-RING ligases (CRLs), respectively. In
both the APC/C and CRLs, an N-terminal b-strand of the
RING domain subunit is integrated within the b-sheet of
theC-terminal domain (CTD)of the cullin subunit.Asdiscussed
below, the catalytic module incorporates two conformationally-
variable domains, the RING domain of Apc11 (Apc11RING) and
the WHB domain of Apc2 (Apc2WHB), both attached to the
CTD of Apc2 (Apc2CTD) by flexible linkers. The conformatio-
nal flexibilities of Apc2WHB and Apc11RING have important
implications for APC/C catalysis and regulation.
Together, the coactivators and Apc10 form the substrate
recognition module, with the coactivator’s WD40 b-propeller
domain being primarily responsible for mediating degron rec-
ognition (D box, KEN box and ABBA motif) [64–71]. Optimal
D-box recognition requires the core APC/C subunit Apc10
(Doc1 in S. cerevisiae) [54,72,73]. The substrate recognition
and catalytic modules represent the key functional subunitsof the APC/C, reflected in their high degree of conservation.
It is striking that these two functional modules represent
only 15% of the total mass of the molecule. Most of the
APC/C mass is conferred by the seven large scaffolding sub-
units, four of which form homo-dimers—further contributing
to the high relative mass of the scaffolding module [74].
Remarkably, the majority of APC/C subunits, particularly
the scaffolding subunits, are composed of multiple repeat
motifs. Five scaffolding proteins are tetratricopeptide repeat
(TPR) proteins, being composed of 13–14 TPRmotifs arranged
in contiguous arrays. TPR proteins, ubiquitous in all three
domains of life, were first discovered in what were later ident-
ified as yeast APC/C subunits [75–78]. Their presence in
multiple protein complexes of diverse functions such as the
APC/C indicates a role in mediating protein–protein inter-
actions and the assembly of multi-protein complexes [79].
Later, atomic resolution structural analysis of the APC/C pro-
vided a mechanistic rationale for many of the previously
characterized TPR mutations [80–83].
The four canonical TPR proteins (Apc3, Apc6, Apc7, Apc8)
are structurally highly homologous, being composed almost
entirely of 14 TPR motifs. These self associate to form homo-
dimers [81–83]. Apc1, the largest APC/C subunit, features
another type of motif that is only observed in Apc1 and the
Rpn1 and Rpn2 subunits of the 19S regulatory subunit of the
proteasome (in exactly the same number and arrangement)
[84]. These approximately 40-residue motifs are termed the
PC (proteasome-cyclosome) repeat [85]. Although not discern-
able in sequence, cryo-electron microscopy (cryo-EM) studies
revealed that Apc1 contains an N-terminal seven-bladed
b-propeller domain [80,86]. Apc4 also comprises a b-propeller
domain [87]. Finally, four small intrinsically disordered
subunits (vertebrate Apc12, Apc13, Apc15, Apc16) function
as TPR-accessory subunits. These subunits interact with TPR
subunits and, as explained later, Apc12, Apc13 and Apc16
stabilize TPR subunits and mediate inter-TPR interactions
[51,54,56,80,86,88,89]. Apc15 is not required for APC/C assem-
bly. It functions to negatively regulate the SAC by controlling
the stability of the Cdc20 subunit of the MCC through APC/
C-dependent auto-ubiquitination [59,90–95].
Structural investigations of the APC/Cwere initiated some
18 years ago, shortly after its discovery in 1995 [1–3]. Initial
efforts focused on a complementary approach of crystallogra-
phy of individual APC/C subunits and small sub-complexes
and homologous proteins [71,81–84,87,89,96–100], together
with single particle cryo-EM studies of the intact complex that
represented various functional states of the complex purified
from endogenous sources: budding yeast, fission yeast,Xenopus
and human [73,101–107]. A combination of crystallography of
individual APC/C subunits, native mass spectrometry [74]
and electron microscopy provided information on the subunit
stoichiometry of the APC/C (table 1).
The recent progress in understanding the structure and
mechanisms of the APC/C through atomic resolution struc-
tures of various functional states of the complex resulted
from technical developments in reconstituting the recombi-
nant APC/C [74,91,108] together with recent advances in
single particle cryo-electron microscopy (direct electron
detectors and software for image analysis and 3D-reconstruc-
tions) [109]. Recent EM studies have focused on reconstituted
human APC/C complexes [80,86,92,93,99,110–112].
In 2014 a 7.4 A˚ resolution structure of the reconstituted
APC/CCdh1.substrate complex was published [86]. At 7.4 A˚
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4resolution the secondary structural architecture can be
defined. Alpha-helices are resolved as rod-like structures,
whereas b-sheets are visualized as planar structures. The sub-
unit assignment of the electron microscopy (EM) density map
was determined based on two approaches. One was a sub-
unit deletion approach where the structures of reconstituted
APC/C complexes lacking defined subunits were compared
with the wild-type complex [74]. Difference density due to
the deleted subunit could be assigned to a specific subunit.
In a related approach, comparing two complexes that share
a common subunit allows its identification. However Apc1,
an essential subunit required for APC/C stability, which
therefore cannot be deleted without disrupting the entire
complex, was identified based on a process of elimination
and by recognizing architectural features of the PC domain
in the EM density map [80,86]. Finally, Apc13 in S. cerevisiae
was identified through locating GFP fused to its C-terminus
[74]. Importantly, EM density for Apc2CTD was weak and dif-
fuse whereas that for Apc11RING and Apc2WHB was not
visible, indicating a high degree of conformational flexibility
of the catalytic module. Conformational heterogeneity was
also confirmed through 3D classification of the cryo-EM data-
set [86]. Altogether, the EM studies revealed a striking degree
of structural conservation from yeast to metazoan. The APC/
C of higher eukaryotes differs from yeast because of an
additional TPR subunit (Apc7) situated on the top of the
TPR lobe that interacts only with Apc3 (table 1). The role of
Apc7 has yet to be defined.
The 7.4 A˚ resolution structure of the APC/C was soon fol-
lowed by a near-atomic resolution structure of the complex of
APC/CCdh1 with the inhibitor Emi1 (APC/CCdh1.Emi1) [80].
This structure was at 3.6 A˚ resolution overall, but a local resol-
ution map showed that the more rigid regions of the mapwere
closer to 3.2 A˚ resolution. Two regions in particularwere recov-
ered at lower resolution (approx. 5 A˚) due to their higher
relative flexibility. These were the catalytic module formed of
Apc11 and Apc2CTD, and the coactivator Cdh1.
The 3.6 A˚ resolution cryo-EMmap of APC/CCdh1.Emi1 pro-
vided the basis for understanding the detailed architecture of
the APC/C and served as a template for understanding sub-
sequent different functional states, some at lower resolution.
Building of the atomic-resolution model was based on fitting
of atomic coordinates of X-ray structures of most of the large
subunits and close homologues. For Apc1, fitting to the
N-terminal WD40 domain and densities adjacent to its central
PC domain (Apc1PC) that lack structural homologues was per-
formed ab initio. The TPR accessory subunits Apc13, Apc15 and
Apc16 were also built ab initio [80].
The APC/C adopts a triangular shape delineated by a lat-
tice-like shell organized into two sub-structures (figure 1)
[80,86]. The back and top of the complex is formed from a
bowl-shaped TPR lobe, an assembly of the four canonical
TPR proteins (Apc3, Apc6, Apc7, Apc8) and three TPR acces-
sory subunits (table 1). The base of the APC/C comprises the
platform subunits Apc4 and Apc5, together with two
(non-PC) domains of Apc1. Apc1PC extends from the platform
to contact the TPR lobe. Together, the TPR lobe and platform
sub-structures define a central cavity. The degron recognition
module of coactivator and Apc10 is located at the top of the
cavity with Apc10 interacting extensively with Apc1PC. The
catalytic module of Apc2-Apc11 is positioned at the periphery
of the platform such that Apc2CTD and associated Apc11 are at
the front of the cavity situated directly below Apc10 and Cdh1.
(a) (b)
180°
Apc7A 
Apc7B 
Apc1PC 
Apc4 
Apc2 
Apc5 
Apc15 
Apc3A 
Apc12A 
Apc6A 
Apc13 
Apc16 
Cdh1WD40
Apc10
Apc8A 
Apc7A 
Apc7B 
Apc1PC
Apc4 
Apc2 
Apc3A 
Apc12B 
Apc5 
Apc8B 
Apc3B 
Apc1WD40 
Apc6A 
Cdh1C Box
Emi1D box
Emi1LRR 
Emi1ZBR
Cdh1IR Apc10IR
Apc8B 
TPR lobe 
platform 
Apc11RING
Apc2CTD
Figure 1. Overall structure of the human APC/CCdh1.Emi1 complex. (a) and (b) Two orthogonal views of the APC/C. Large APC/C subunits are represented as cartoons,
whereas small APC/C subunits (Apc12, Apc13, Apc15, Apc16), the IR tails of Cdh1 and Apc10, the Cdh1 NTD and the Emi1 inhibitor are shown as space filling
representations. The TPR and platform sub-structures are labelled. The two subunits of the canonical homo-dimeric TPR subunits (Apc3, Apc6, Apc7 and Apc8) and
Apc12 are labelled with the suffix ‘A’ and ‘B’. Apc2CTD and Apc11RING form the catalytic module, Cdh1 and Apc10 generate the substrate recognition module. PDB
4UI9, from Chang et al. [80].
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5The canonical TPR proteins form structurally related
V-shaped homo-dimers [81–83]. Each subunit comprises an
a-helical solenoid with two turns of TPR helix. Whereas the
N-terminal TPR helix forms the homo-dimer interface,
the C-terminal TPR helix creates a protein-binding groove.
Apc6 binds its accessory subunit Apc12 through this groove
(figure 1) [82,89], stabilizing Apc6 [89], whereas the Apc3
and Apc8 homo-dimers use one of their dyad-related
C-terminal grooves to engage the coactivator subunits (either
Cdc20 or Cdh1) (figures 1 and 2) [60,80,86]. Within the TPR
lobe, the four canonical TPR proteins stack in a parallel array
generating a left-handed super-helix that adopts pseudo
dyad-symmetry. Together the TPR accessory subunits Apc13
and Apc16 (and presumably Apc9 in S. cerevisiae) interact
with structurally and symmetry related sites on seven of the
eight TPR subunits to stabilize the TPR lobe and contribute
to defining the order of TPR protein assembly [80].
Apc10 and both coactivators share structurally related
C-terminal Ile-Arg motifs (IR tails) that interact with the
C-terminal TPR motifs of Apc3 (figures 1 and 2a,b) [66,88,
96,113,114]. Additionally, coactivators comprise a C-box
motif within theirN-terminal domain (NTD) [68] thatmediates
interactions with the APC/C [68,113], dependent on Apc8
[115]. Due to the presence of multiple binding sites on the
TPR lobe, the pseudo dyad-symmetry of the TPR lobe has
important consequences for mechanisms of interaction with
coactivators and substrates. Not only does the dyad symmetry
of each TPR protein mean that there is multiplication of
protein/ligand binding sites (for example the common IR
tails of coactivator and Apc10 interact with separate subunits
of theApc3 homo-dimer (figure 2a,b)), but also the IR-tail bind-
ing site on Apc3 is structurally related to the C-box binding site
on Apc8B, a paralogue of Apc3 (figure 2c). The mechanism of
interaction of the IR tail with Apc3 is structurally analo-
gous to that of the R[F/Y]I motif of the C box with the C-boxbinding site on Apc8B [80]. Because of this, the structurally
equivalent C-box binding site on Apc8A is capable of binding
the IR tail of Cdc20MCC (in the APC/CMCC complex) [92,93].
A conformational transition involving the C-terminal TPR
motifs of Apc3A occludes the coactivator IR-tail binding
pocket in the absence of the IR-tail ligand [60,80,100]. Finally,
regions of the NTD of coactivator also interact with Apc1PC
(figure 3c). Thus the degron-recognition WD40 domains of
the coactivators are connected to the APC/C scaffold through
three sites, attached through flexible linkers. This allows for
conformational flexibility of the WD40 domain.
In the platform, analogous to the Apc6–Apc12 inter-
action, the C-terminus of Apc15 inserts into the TPR groove
of Apc5 as an extended chain, with its N-terminal a-helix
(Apc15NTH) bridging Apc5 and Apc8 [80].3. Coactivators are primarily responsible for
degron recognition
The APC/C recognizes and ubiquitinates a variety of cell cycle
substrates in a cell-cycle-dependent manner. Selection of
substrates in a temporal manner is dependent on a variety of
factors, but critical among these is the role of coactivators
[29]. The APC/C is inactive without coactivator. One func-
tion of coactivators is to provide degron recognition sites
that engage degrons present in most APC/C substrates
[66,69–71], thereby recruiting substrates to the APC/C
(figures 1, 3a,b, 4 and 5). In a few exceptions, for example
Nek2A, the core APC/C recognizes substrates, bypassing
degron recognition sites on the coactivator. However, Nek2A
ubiquitination still relies upon the coactivator-induced
stimulation of UbcH10-binding to the APC/C [86,117].
Due to the critical role coactivators play in defining APC/C
activity, regulation of APC/C activity by phosphorylation and
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Figure 2. The IR-tail and C-box binding sites of Apc3 and Apc8 respectively, are homologous. (a) Cdh1 IR-tail binding site. (b) Apc10 IR-tail binding site. (c) C-box
binding site on Apc8B. The Ile and Arg side chains of the IR tail of both Cdh1 and Apc10 interact with a site on Apc3 that is homologous to the binding sites for
Arg(47) and Ile(49) of the Cdh1 C box on Apc8B. The C box (DR[F/Y]IPxR) forms additional contacts to Apc8B as shown. PDB 4UI9, from Chang et al. [80].
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6inhibitory complexes such as the MCC, Emi1 and Acm1 is
exerted primarily at the level of coactivators, either by control-
ling their interaction with the APC/C or by controlling
coactivator interaction with degrons. Cdc20 activates the
APC/C from early mitosis to anaphase after which Cdh1
binds to the APC/C through to late G1. Switching of these
two highly structurally conserved and related coactivators at
anaphase changes the substrate specificity and regulatory
properties of the APC/C. Cdc20 is thought to recognize a
restricted set of substrates (specifically cyclin A, cyclin B and
securin), whereas Cdh1 is proposed to have a broader substrate
specificity, being able to ubiquitinate all Cdc20 substrates, and
in addition recognizes the Aurora A and B kinases, which are
not substrates of APC/CCdc20 [118]. Aurora kinases are recog-
nized by APC/CCdh1 through their essential N-terminal A box
motif [119]. The role of the C-terminal D box of Aurora kinases
is disputed, as discussed in Davey & Morgan [120]. Both coac-
tivators mediate interactions of substrates harbouring D-box
and KEN-box motifs to the APC/C. Optimal interactions of
the D box also require the Apc10 subunit [54,72,73]. The
ABBA motif is recognized by vertebrate Cdc20 [121], and
S. cerevisiae Cdh1 [71] and Cdc20 [120,122]. In S. cerevisiae aspecific coactivator termed Ama1 controls meiosis [123,124] that
in turn is antagonized by the Mnd2 (Apc15) subunit [125,126].
To understand structurally how coactivators recognize
D-box and KEN-box substrates, advantage was made of the
fact that many APC/C inhibitors incorporate pseudo-substrate
motifs that mimic D-box and KEN-box degrons in order to
block substrate recognition. These inhibitors interact with
higher affinity with coactivators than do substrates, thereby
facilitating the biochemical isolation and crystallization of
these complexes. A structure of the MCC from Schizosaccharo-
myces pombe, a complex of Cdc20, Mad2 and BubR1/Mad3,
revealed how a KEN box and D box present in BubR1/Mad3
interact with their respective binding sites on the b-propeller
domain of Cdc20 [69]. These findings were confirmed and
extended in a structure of the b-propeller domain of Cdh1 in
complex with Acm1, a Cdh1 specific inhibitor from
S. cerevisiae [71]. The latter structure also revealed how the
ABBA motif (A motif in Acm1 terminology [127]) interacts
with Cdh1 (figures 3 and 4). A further study in which
human Cdc20 was crystallized with a peptide modelled on
the BubR1 KEN box also revealed details of Cdc20 interactions
with the KEN-box motif [70].
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(a)
Figure 3. Coactivators interact with Apc1 and Apc3 and create a D-box co-receptor with Apc10. (a) Overview of the APC/C with the Cdh1 coactivator subunit. Based
on the APC/CCdh1.Emi1 coordinates (PDB 4UI9) [80] with the KEN box and ABBA motif modelled on the S. cerevisiae Cdh1–Acm1 complex (PDB: 4BH6) [71]. Except
for the D box, Emi1 coordinates are not shown. (b) Close-up view of the D-box co-receptor formed from Cdh1 and Apc10. (c) Cdk1-dependent phosphorylation of the
NTD of Cdh1 blocks its binding to the APC/C. Red spheres indicate sites of inhibitory phosphorylation.
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7D box. The classical APC/C degron is the destruction box
or D box, a ten-residue motif (RxxLx[D/E][Ø]xN[N/S])
(figure 5a,c) first characterized in B-type cyclins as being
necessary and sufficient for APC/C mediated ubiquitination
[128–130]. Mutation of any of the three most highly con-
served residues, Arg (P1), Leu (P4) or Asn (P9), ablated the
destruction signal [128]. The D box binds in a mainly
extended conformation to a shallow groove at the side of
the b-propeller, found between the two b-blades 1 and 7
(figures 3b and 4a). The essential Leu (P4) residue anchors
the D box to the channel within a hydrophobic pocket,
whereas the N-terminal Arg (P1) residue interacts with an
acidic pocket at the N-terminus of the channel (figure 4a).
A conserved acidic residue at P6 interacts with an invariant
Arg, whereas a hydrophobic residue at P7, conserved in
many D-box motifs, interacts with a hydrophobic surface of
the b-propeller (figures 4a and 5a,c) [69,71]. The side chain
of P3 abuts a conserved Phe of the coactivator, likely account-
ing for the high occurrence of residues with small
unbranched side chains at this D-box position (figures 4a
and 5a,c). Although Arg and Leu are strongly preferred at
P1 and P4, respectively, even these two residues arenot strictly necessary. For example, in Drosophila melanogaster
cyclin A [131] and Homo sapiens cyclin B3 [132], Phe is
substituted for Leu.
Significantly, the conserved C-terminal hydrophilic resi-
dues (P8 to P10) do not interact with the coactivator, however
the cryo-EM structure of APC/CCdh1.Emi1 (where the inhibitor
Emi1 incorporates a D box) showed clear EMdensity extending
from the P7 residue of theD box (interactingwith the D-box site
on Cdh1) to Apc10 [80]. This showed that the C-terminus of the
D box interacts with a hydrophilic surface of Apc10 [80,96,97]
involving polar and charged residues on two surface-exposed
loops (the 80s and 140s loops) (figure 4b). This highly conserved
region is required for D-box-dependent APC/C E3 ligase
activity, and this potentially dynamic hydrophilic surface
may allow for the accommodation of a variety of small polar
residues at D-box positions P8 to P10 (figure 5a). Disruption
of the 140s loop impairsD-box-dependent substrate recognition
[133] and Ala substitutions of Ser88 and Asn147 of Apc10
attenuatedAPC/CCdh1 activity [80]. AlthoughApc10 primarily
interacts with D-box residues P8 to P10, its 80s loop also
contacts N-terminal residues of the D box (figure 4b). For
example, the side chain of Glu87 (invariant in Apc10
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Figure 4. Substrate recognition is mediated by coactivators and Apc10. (a) D-box receptor on Cdh1, (b) D-box co-receptor (Cdh1 and Apc10), (c) KEN-box receptor on
Cdh1, (d ) ABBA-motif interactions with Cdh1. Coordinates in (a,c,d ) are based on the S. cerevisiae Cdh1–Acm1 complex (PDB: 4BH6) [71]. (b) Based on APC/CCdh1.Emi1
complex (PDB 4UI9) [80].
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8orthologues) is sandwiched betweenP2, P5 and P7 of theDbox,
perhaps explaining the occurrence of basic residues at these
positions, especially for the non-canonical D-box sequences
(discussed below) (figure 5a,c).Notably, Cdk1-phosphorylation
at P2 (Pro is commonat P3) negatively regulatesAPC/C-depen-
dent substrate ubiquitination, for example Dbf4 [122], possibly
due to the electrostatic repulsion between a phosphate group at
P2andGlu87. Thus, theDbox is a bipartitedegron comprising a
coactivator-interacting N-terminal (RxxLx[D/E][Ø]) motif and
a hydrophilic C-terminal-Apc10 binding segment. Coactivator
and Apc10 create a D-box co-receptor for recognition of the
bipartite degron. The atomic resolution structures of D-box
motifs engaged by coactivators alone [69,71] and in complex
with APC/C-coactivator complexes [60,80] rationalize the resi-
due preferences at all 10 positions of the D box. Moreover, the
preferences for an acidic residue at P6 and basic residue at P2
are consistent with the promotion of substrate ubiquitination
by D-box phosphorylation at P6 [134] and substrate
stabilization by phosphorylation at P2 [122].
KEN box. Another APC/C degron, the KEN motif ([DNE]-
KENxxP), is commonly present inAPC/C substrates usually in
addition to the D box [135]. Efficient ubiquitination by either
APC/CCdc20 or APC/CCdh1 of substrates harbouring both Dand KEN boxes is dependent on both degrons [54,64]. By
forming a 310 helix, the three consecutive residues of the
KEN box face in the same orientation and engage the top sur-
face of the b-propeller (figures 3b and 4c) [69–71]. The KEN
box is usually immediately C-terminal to acidic residues
(figure 5b,d ), and the structure of the KEN box–coactivator
complex suggested that these would engage a positively
charged patch on the b-propeller. A frequently observed Asp
or Asn residue at P-1 stabilizes the KEN box conformation by
forming a hydrogen bond to the Asn of the KEN box
(figure 4c) [71]. Proline residues one to two residues C-terminal
of the KEN box would direct the polypeptide chain away from
the surface of the b-propeller.
ABBA motif. The A motif was discovered in the S. cerevisiae
Cdh1 inhibitor Acm1 [127,136]. Later bioinformatics studies
identified the ABBA motif as a general class that includes the
A motif as a six-residue motif (Fx[ILV][FY]x[DE]) common to
vertebrate cyclin A (and S. cerevisiae Clb5), BubR1, Bub1 and
Acm1 [120–122]. Although the Amotif was originally thought
to confer specificity for S. cerevisiae Cdh1 [71,127], the situation
is more complicated. Cdc20 also binds the ABBA motif—
variations in non-consensus residues confer the specificity for
S. cerevisiae Cdh1. Glu65(P5) of the ABBA motif of Acm1
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Figure 5. Degron consensus sequences. (a) Sequence motif of D box derived from 68 APC/C substrates [71]. Sequence motif determined using multiple expectation
maximization for motif elicitation (MEME) [116]. (b) Sequence motif of KEN box derived from 46 APC/C substrates [71]. (c) Alignment of consensus D box degron
with non-canonical D box degrons. (d ) Consensus KEN box. Adapted from [71].
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9contacts Lys333 in S. cerevisiae Cdh1 that is a Thr in S. cerevisiae
Cdc20 [121]. Residues of human Cdc20 required for ABBA
motif binding are not conserved in human Cdh1 (although
are conserved in S. cerevisiae Cdh1), explaining the inability
of human Cdh1 to recognize the ABBAmotif [121]. A structure
of Acm1 in complex with S. cerevisiae Cdh1 revealed that the
ABBA motif forms an extended structure and binds to the
inter-blade groove between b-blades 2 and 3, through a related
mechanism to the D box (figure 4d ). The side-chains of the
three conserved non-polar residues anchor the ABBA motif
to the ABBA-motif binding groove, with the Asp at P6 forming
a salt-bridge with an Arg of blade 2 [71].
Non-canonical degrons. In addition to the D box, KEN box
and ABBA motif, non-canonical degrons have also been
identified (figure 5c). However, some of these are likely to
be variants of the well-characterized D box and KEN box
degrons [71,120]. For example, the conserved Arg (P1) at
the N-terminus of the D box can be substituted with Lys,
His or Gln although this is often accompanied by a Lys at
P7 which can interact with the acidic patch at the N-terminus
of the D-box binding channel [71]. The O box identified as an
APC/C degron in Orc1 closely matches the D-box consensus
[137], suggesting it may interact with the D-box receptor [71],
consistent with the ability of a D-box peptide to interfere with
O-box recognition by APC/CCdh1 [137]. A D-box peptide also
inhibited APC/CCdh1-catalysed ubiquitination of the Spo13
[138] and Cin8p [139], substrates that harbour non-canonical
D-box motifs (figure 5c) [71]. Peptides modelled on the
non-canonical D-box motifs of Cin8p, the O box and Spo13
inhibited the D-box-dependent ubiquitination of the budding
yeast substrate Hsl1, consistent with the idea that these motifsinteract with the D-box receptor of APC/CCdh1 [71]. In mam-
mals, the CRY box (CRYxPS) within the NTD of Cdc20
mediates APC/CCdh1-dependent Cdc20 destruction in
oocytes and embryos [140]. Insights into how the CRY box
might interact with Cdh1 were provided by cryo-EM struc-
tures of the APC/CMCC [92,93] (discussed in §8). These
showed that the CRY box of the MCC Cdc20 subunit interacts
with the WD40 domain of Cdc20 of APC/CCdc20 in proximity
to the D-box binding site.
In addition to modulation of APC/C–substrate affinities
by substrate phosphorylation in or adjacent to the degron,
ubiquitination of Lys residues within or in close proximity
to degrons may influence APC/C–substrate affinities. One
example of this is that the KEN-box Lys residue is one of
the most frequently ubiquitinated sites in vivo [141]. Modifi-
cation of the KEN box would be expected to reduce APC/
C–substrate affinities.
Discovery of new APC/C substrates will be facilitated
by high-throughput automated approaches based on
protein micro-arrays such as the extract-based functional
assays [142,143].4. The APC/C pairs with two E2s to
assemble polyubiquitin chains
The APC/C is a RING domain E3 ligase. RING domains inter-
act directly with their canonical E2s and bring these into close
proximity with substrates bound to degron recognition sites
situated elsewhere on the E3 ligase [144]. Metazoan APC/C
assembles atypical Lys11-linked chains to promote proteolysis
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10and mitotic exit [145,146], in a process involving two distinct
E2 activities. Chain formation is initiated with the E2
UbcH10 (also termed Ube2C) [147,148], whereas Ube2S is pri-
marily responsible for chain extension [149–152]. Ube2S
interacts with the acceptor ubiquitin to generate Lys11-linked
chains through a substrate-assisted catalytic mechanism in
which Glu34 on the acceptor ubiquitin activates and orients
the target Lys11 to attack the donor ubiquitin conjugated to
Ube2S [152]. UbcH10 and Ube2S act in concert to generate
branched chains (mixed K11 and K48 linkages). The ubiquitin
chain topology determines the efficiencyof proteasome-depen-
dent proteolysis of the ubiquitinated substrate [153–156].
UbcH10 alone is competent to generate short ubiquitin
chains of mixed K11, K48 and K63 linkage [157,158]. Neither
UbcH10 nor Ube2S are essential, suggesting an alternative E2
can function in place of UbcH10 in vivo, likely to be UbcH5
[159]. However, Ube2S is essential for optimal release from a
SAC-dependent arrest, possibly due to its role in reactivating
the APC/C on cessation of SAC signalling [149–151]. In
S. cerevisiae the APC/C generates canonical Lys48-linked
chains also using two E2s: the initiating E2 Ubc4 and the
elongating E2 Ubc1 [160]. A UBA domain in Ubc1 is required
for processivity [160] by enhancing Ubc1 association with the
APC/C in competition with Ubc4 [161].
4.1. Monoubiquitination catalysed by UbcH10
Cryo-EM studies of human APC/CCdh1 in complex with
UbcH10 and Ube2Swith andwithout ubiquitin have provided
detailed mechanistic insights into the process of substrate ubi-
quitination [80,99,111,112]. UbcH10 is a canonical E2 that
interacts with the RING domain of Apc11 [80,111]. In human
APC/C, the catalyticmodule is a regionof conformational flexi-
bility [60,86]. Binding of UbcH10, but not Ube2S, is dependent
on a conformation changemediated by the coactivator subunit
(figures 6 and 7) [86,110]. Thus, coactivators are required for
both substrate recognition and for stimulating the catalytic
activity of the APC/C [117]. This conformational change
involves a movement of the catalytic module from a ‘down’
to an ‘up’ position. In the ‘down’ position, Apc11RING is in con-
tact with Apc5 of the platform, blocking the UbcH10-binding
site. On conversion to the coactivator-bound state, movement
of the catalytic module to an upward position exposes the
UbcH10-binding site on Apc11RING-Apc2WHB, resulting in at
least a 10-fold increased affinity for UbcH10 [86]. In this state
the catalytic module is flexible with weak density recovered
and conformational heterogeneity for a variety of ternary com-
plexes [60,86]. Coactivators also increased the catalytic
efficiency of S. cerevisiae APC/C (decrease in Km and increase
in Vmax) [163], although this may result from a mechanism
other than a coactivator-induced conformational change
(D Barford & E Va´zquez Ferna´ndez 2017, unpublished data).
The interaction of the zinc binding region (ZBR) domain of
the inhibitor Emi1 with Apc11RING stabilizes the conformation
of the catalytic module because the ZBR domain bridges
Apc1PCwith Apc11RING and Apc2CTD (figure 1a). This allowed
definition of Apc11RING and Apc2CTD to a local resolution of
approximately 6 A˚ [80] and it showed for the first time
how Apc11RING interacts with Apc2CTD. The juxtaposition of
Apc11RING and Apc2CTD is similar to the swung out con-
formation of Rbx1RING in activated Cul5-Rbx1 [164].
Engagement of UbcH10 with Apc11RING is essentially similar
to other RING domain–E2 interactions (figure 6b) [80,111].Density for UbcH10 was poorly resolved, probably due
to the low stoichiometry of UbcH10–APC/C interactions
and conformational flexibility of the catalytic module. The
Apc11RING–UbcH10 interface was confirmed by a detailed
mutagenesis study by Schulman and colleagues [111]. On
interacting with UbcH10, the catalytic module rotates by 128
relative to its position in the APC/CCdh1.Emi1 complex [80].
Importantly no EM density was visible for ubiquitin in the
APC/CCdh1-UbcH10ubiquitin cryo-EM maps [80,111]. This
would indicate that the ubiquitin moiety must be mobile,
and only transiently adopts the closed E2ubiquitin confor-
mation that primes the E2ubiquitin thioester bond to
stimulate the intrinsic catalytic activity of E2ubiquitin
[152,165–169]. Formation of the closed E2ubiquitin confor-
mation, where the ubiquitin moiety interacts with the RING
domain through its Ile36 and E2 through its Ile44, as a require-
ment for optimal substrate ubiquitination, is based on the
finding that mutating either Ile36 or Ile44 residues in ubiquitin
virtually eliminated ubiquitination of APC/C substrates [80].
The APC/C is reminiscent of other single domain RING and
U-box E3s that bias the E2ubiquitin conformation from mul-
tiple extended states to the closed state [168,170]. As discussed
elsewhere [80,111], an interesting possibility is that substrate
initiation motifs that promote lysine ubiquitination [158] may
induce a closed UbcH10ubiquitin conformation.
The study of Schulman and colleagues revealed that
Apc2WHB forms an unusual interaction with the backside of
UbcH10 [111]. This interaction follows a rigidification of the
WHB domain (which is mobile in UbcH10-free structures)
induced upon UbcH10 binding (figure 7c). Apc2WHB is essen-
tial and specific for APC/C-UbcH10-dependent substrate
modification, but is dispensable for UbcH5 activity. The
activity of Ube2S, which does not interact with Apc2WHB, is
also independent of Apc2WHB [111]. Apc2WHB both enhances
APC/C-UbcH10 affinity, but importantly also greatly stimu-
lates (by more than 100-fold) the catalytic activity of UbcH10,
likely by stabilizing the E2ubiquitin closed conformation
through an allosteric mechanism. Since the WHB-binding
interface of UbcH10 differs substantially from its counterpart
in UbcH5, similar interactions between UbcH5 and Apc2WHB
are not possible, thus explaining how Apc2WHB contributes to
UbcH10 specificity [111].
4.2. Polyubiquitination catalysed by Ube2S
The processive ubiquitination reaction catalysed by Ube2S
involves modification of a constantly changing substrate that
is the growing distal ubiquitin moiety of the polyubiquitin
chain. Biochemical studies showed that UbcH10 and Ube2S
do not compete for the same binding site on the APC/C
[150,152], suggesting that Ube2S differs from canonical E2s
by not interacting with the RING domain of Apc11, a notion
also consistent with the observation that Ube2S catalyses for-
mation of unattached K11-linked polyubiquitin chains [171].
APC/C–Ube2S interactions are dependent on the C-terminal
LRRL motif of Ube2S [86,154,172,173]. The APC/C dramati-
cally improves the catalytic efficiency of Ube2S-mediated
Lys11-linked chain assembly [99,173]. This stimulatory effect
of the APC/C requires a surface centred on Ala46 of the accep-
tor ubiquitin, indicating that APC/C tracks the distal ubiquitin
of a growing ubiquitin chain [173]. This finding explains how
the APC/C generates ubiquitin chains without altering its
interactions with substrates and E2s.
(a)
Apc7A 
Apc7B 
Apc1PC
Apc4 
Apc2 
Apc5 
Apc3A 
Apc10
Apc8A 
Apc6A 
Apc11RING 
Apc7A 
Apc7B 
Apc1PC
Apc4 
Apc5 
Apc3A 
Cdh1WD40 Apc10
Apc8A 
Apc6A 
UbcH10 Ube2S 
Apc7A 
Apc7B 
Apc1PC
Apc4 
Apc5 
Apc3A 
Cdh1WD40
Apc10
Apc8A 
Apc6A 
Apc2WHB
KEN
ABBA
D box
dUb 
aUb 
Apc11RING 
Apc2CTD 
Apc11RING
exosite
Apc11RING
D box
Apc2CTD 
Apc2CTD 
(b) (c)
Figure 6. APC/C ubiquitination reaction. (a) Apo APC/C. In the absence of coactivator the catalytic module adopts a ‘down’ inactive conformation. UbcH10 binding to
Apc11RING is blocked by Apc5, and Apc5 prevents the correct location of Apc2WHB required to engage UbcH10. EM density for Apc11RING is weak indicating RING
domain flexibility. PDB 5G05 from Zhang et al. [60]. (b) Complex of APC/CCdh1.substrate with a UbcH10  ubiquitin conjugate. Apc2WHB becomes ordered and engages
UbcH10. dUb: modelled donor ubiquitin conjugated to UbcH10. The C-terminus of dUb is indicated with a red sphere. PDB 5A31, from Chang et al. [80]. PDB for
Apc2WHB 4YII Chang et al. [111]. (c) APC/CCdh1.substrate-Ube2SUb complex. Ube2S is partially built. aUb: acceptor ubiquitin bound to the Apc11RING exosite. PDB
5L9T, from Brown et al. [112]. The figure is based on previous work [60,80,111,112].
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11Brown and colleagues [99] in agreement with Kelly et al.
[173] showed that the APC/C increased Ube2S catalytic effi-
ciency to massively increase polyubiquitination. Although
this catalytic enhancement requires Apc11RING, two lines of
evidence suggested that this did not involve the canonical E2-
binding surface on Apc11RING. Mutagenesis studies identified
a novel surface on Apc11RING (termed the exosite) required
for Ube2S activity, a result complemented by NMR data show-
ing chemical shift perturbations in this region of Apc11RING in
the presence of ubiquitin. Conversely, acceptor ubiquitin
mutants with specific defects in APC/C-Ube2S-dependent ubi-
quitination [99,152,173] map to a RING-binding surface on
ubiquitin identified by NMR [99]. In a subsequent study, the
structural basis for Ube2S-catalysed ubiquitin chain extension
was defined [112]. A cryo-EM reconstruction of APC/CCdh1
in complex with Ube2S revealed that the Ube2S UBC (ubiquitinconjugating) domain interacts with Apc2, rationalizing the
deleterious effects of mutations of the aC and aD helices
(figure 6c) [99,112,173]. Its LRRL C-terminus interacts at a site
between Apc2 and Apc4, as previously determined for the
Emi1 LRRL tail in the APC/CCdh1.Emi1 structure [80]. The
distal (acceptor) ubiquitin moiety of the ubiquitinated substrate
engages the repurposed exosite on Apc11RING, following a con-
formational change of Apc11RING, presenting its K11 residue to
undergo nucleophilic attack onto the donor ubiquitin conju-
gated to Ube2S. Thus the Apc11RING exosite captures the tip
of the growing polyubiquitin chain promoting its reaction
with Ube2Subiquitin bound to Apc2 (figure 7e).
The relative locations of the UbcH10 and Ube2S binding
sites on the APC/C also fit with their different functions—
priming and elongation, respectively (figures 6 and 7).
UbcH10 is located closer to the degron binding site on the
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Figure 7. Schematic of ubiquitination reaction catalysed by the APC/C. (a) In the apo state, the downward position of the catalytic module would cause a clash between
Apc5 and both UbcH10 and Apc2WHB (as in the APC/CCdh1.substrate–UbcH10  ubiquitin complex). (b) Binding of coactivator shifts the catalytic module (Apc2 and Apc11) to
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12substrate-recognition module, facing into the central cavity,
and this is consistent with the relatively close proximity of
the preferred target lysines to APC/C degrons (figures 6b
and 7c). In contrast, Ube2S is sited on the periphery of the
molecule, able to accept the distal ubiquitin moiety on the
polyubiquitin chain. The growing polyubiquitin chain can
then be easily accommodated on the outside of the molecule
(figures 6c and 7e).
4.3. Multiubiquitination catalysed by UbcH10
The repurposing of Apc11RING that stimulatesUbe2S-catalysed
ubiquitin chain extension also plays a role in protein multi-
ubiquitination catalysed by UbcH10 through its interaction
with the canonical E2-binding site on Apc11RING. A cryo-EM
structure of a monoubiquitinated substrate bound to
APC/CCdh1-UbcH10ubiquitin showed that the substrate-
conjugated ubiquitin moiety interacted with the Apc11RING
exosite [112], a finding supported by mutagenesis data reveal-
ing that multi-ubiquitination catalysed by UbcH10 was
defective in the Apc11RING exosite mutant. The structure
suggests a model for how an interaction between the Apc11
exosite and a substrate conjugated ubiquitin would increase
substrate affinity and hence processivity (figure 7d ).Importantly, these data are consistent with the proposal that
substrate ubiquitination primes APC/C substrates for further
ubiquitination through a mechanism termed processive
affinity amplification [174].
The inherentweak affinities between theAPC/C–substrate
complex and the E2s UbcH10 and Ube2S were overcome by
employingartificial reinforcement of these interactions through
a three-way chemical linkage involving the substrate, ubiquitin
and E2 [111,112]. The interactions between the Apc11RING exo-
site and ubiquitin were strengthened by generating a ubiquitin
variant (Ubv) with substantially increased affinity for
Apc11RING [112]. In another approach to stabilize APC/
CCdh1.substrate interactions with UbcH10, either UbcH10 was
directly fused to the C-terminus of Apc11 or the LRRL tail of
Ube2S was fused to the C-terminus of UbcH10, enhancing its
affinity 10-fold [80].5. The APC/C controls cell-cycle-dependent
substrate degradation
The capacity of the APC/C to control the degradation of
regulatory proteins in a cell-cycle-dependent manner defines
the ordered progression through distinct phases of the cell
rsob.royalsocietypublishing.org
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13cycle. The factors that affect differential rates of protein degra-
dation during the cell cycle depend upon both changes in the
composition and conformation of the APC/C itself as well as
direct changes to individual substrates, and their intrinsic
processivity. Switching between Cdc20 and Cdh1 contributes
to altering APC/C substrate specificity. Cdh1 directs APC/
C-mediated ubiquitination of the Aurora kinases [118],
which are not substrates of APC/CCdc20. Nevertheless, apart
from this example, there are relatively few instances known
where the timing of substrate degradation can be directly
explained by the switch of coactivator. Apart from coactivator
switching, the two best-characterized regulatory mechanisms
for determining the cell cycle order of APC/C-regulated sub-
strate degradation are the spindle assembly checkpoint and
substrate phosphorylation. :1702045.1. Substrate degradation at the spindle assembly
checkpoint
A fewAPC/C substrates are degraded in earlymitosis (prome-
taphase), for example Nek2A, cyclin A and Hox10, during an
active SAC [175–181]. Thus, ubiquitination of these substrates
is not inhibited by the SAC. These substrates differ from the
canonical D-box and KEN-box-dependent substrates cyclin B
and securin whose ubiquitination is inhibited by the MCC
[24,177,178]. This implies that these early substrates would
incorporate additional novel APC/C-recognition motifs that
do not rely on binding to D-box and KEN-box receptors.
Indeed, in the case of Nek2A, its interaction with the APC/C
occurs in the absence of coactivators [182,183], through a C-
terminal Met-Arg (MR) tail motif that mimics the IR tail of
coactivator and Apc10 [182,183]. However, coactivators are
required to mediate Nek2A ubiquitination [117,181] by indu-
cing a UbcH10-binding site on the APC/C [86]. For Nek2A
to be degraded during an active checkpoint it requires both
its C-terminal MR tail and the adjacent leucine zipper, imply-
ing a requirement for Nek2A dimerization. Deletion of either
motif shifts the degradation to anaphase that is KEN-box
dependent [181,184]. Nek2A binds to apo APC/C, but not
APC/CMCC [181], and its binding required the C-box site of
Apc8, likely through its MR tail (since the IR tail of Cdc20 of
the MCC binds to the C-box binding site of Apc8A [92,93]).
Cyclin A is degraded soon after nuclear envelope break-
down (NEBD) in prometaphase some 20 min before cyclin
B. Importantly cyclin A degradation is not inhibited by an
active SAC, although its degradation is affected by the SAC
[121,176–178]. When the SAC is repressed by the over-
expression of a dominant negative BubR1 mutant, cyclin B1 is
degradedshortlyafterNEBD, similar to cyclinA [177]. In further
support that the SAC is a major cause of the difference in timing
of cyclin A and cyclin B degradation, inactivating the SACusing
the Mps1 kinase inhibitor reversine caused premature cyclin B
degradation, with kinetics similar to cyclin A, and importan-
tly no longer dependent on Apc15 [59], which is required to
reactivate APC/CCdc20 when the SAC is switched off.
Both the N-terminal 165 residues of cyclin A and the Cks
subunit are necessary and sufficient to confer the SAC-resistant
degradation of cyclinA [178,185,186]. Deletion of the cyclin AD
box does not stabilize the protein at prometaphase, or affect
degradation timing later inmitosis, questioning the importance
of this motif in APC/C-dependent recognition [177,178,
182,187]. A region of cyclin A (residues 98–165) C-terminal tothe D box contributes to the degradation timing and this
region (which incorporates the ABBA motif [121]) binds
directly to Cdc20, competing with BubR1 [186]. An ABBA
motif also contributes to the early timing of Clb5 degradation
in S. cerevisiae comparedwith securin andDbf4 [122]. However,
unlike vertebrate cyclin A2, Clb5 degradation is sensitive to the
SAC although there exists a low rate of Clb5 degradation during
a SAC that depends on the ABBA motif [122].
The ABBA motif clearly plays a role in determining the
early destruction of cyclin A2 and Clb5 relative to cyclin B
and securin. However, this may not be entirely due to the abil-
ity of the ABBAmotif to overcome the SAC-induced inhibition
of D-box and KEN-box-dependent substrates. One possibility
is that cyclin A2 is a more processive substrate. This could
be explained if cyclin A2 has a relatively higher affinity for
the APC/C, thus competing effectively for binding sites on
the APC/C. The ABBA motif may contribute to the higher
affinity. However, against the competition argument is the
finding that in S. cerevisiae over-expression of Clb5 did not
alter the relative timing of destruction of the later substrate
securin [188]. It is also interesting that in inactivated Xenopus
egg extracts (where there is a weak checkpoint), mutation of
the ABBA motif (Fx[I/L/V][F/Y]xVD: residues mutated in
bold) toAla had no to little effect on cyclinA degradation [189].
The Cks subunit of the Cdk1–cyclin B1–Cks complex
recruits the complex to the checkpoint-inhibited phosphory-
lated APC/C at prometaphase, but ubiquitination of cyclin
B1 is blocked by the MCC. This prior binding renders
cyclin B1 a better APC/C substrate in metaphase [25].5.2. Phosphorylation can regulate the timing of
substrate ubiquitination
Phosphorylation of D box and KEN box degrons has important
consequences for controlling the timing of APC/C-mediated
protein degradation. Cdk1-dependent phosphorylation of the
P2 site of Dbf4 suppresses its destruction [122], contributing to
the timing of its destruction in mitosis. A bulky negatively-
charged residue at P2 interferes with D-box binding to the
D-box receptor of the coactivator whereas phosphorylation at
the P6 position promotes human securin degradation [134].
The structural explanation for this was discussed in §3. In
contrast, Cdk1-mediated phosphorylation ofS. cerevisiae securin
in close proximity to the KEN box (17 residues C-terminal) and
D box (14 residues N-terminal) reduces the rate of APC/C-
dependent securin ubiquitination some 5–10 fold [190]. Depho-
sphorylation of these sites by Cdc14 therefore promotes securin
degradation. Interestingly, since active separase (produced
as a result of securin degradation) stimulates Cdc14, a positive
feedback loop is generated involving Cdc14-mediated depho-
sphorylation of securin. Together with the partial inactivation
of Cdks atmetaphase due to APC/CCdc20-mediated destruction
ofmitotic cyclins, it increases the rate of securin degradation and
the abruptness of anaphase onset [122,190]. In S. cerevisiae, one
factor delaying securin degradation relative to Clb5, even in
the absence of the SAC, is Cdk1-dependent phosphorylation of
residues proximal to its KEN box.
At S-phase, Cdk-dependent phosphorylation of amino
acids in the immediate vicinity of the D box of Cdc6 blocks
binding to the APC/C, thereby protecting Cdc6 from ubiquiti-
nation, and promoting DNA replication origin licensing [191].
In another example, Aurora A-kinase phosphorylation of the
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14D-box P3 residue stabilizes geminin [192], likely because the P3
position has a preference for non-bulky residues.
5.3. Substrate ubiquitination topology may affect
timing of proteolysis
The pattern of substrate ubiquitination (multi, poly and
branched chains) that favours proteasome-dependent proteol-
ysis (and possibly inhibition of DUB activity) would also
contribute to more effective substrate destruction [153,154].
Processively polyubiquitinated substrates are degraded earlier
in the cell cycle [122,155,193,194]. It is possible that the position
of degrons relative to target lysines affects the efficiency and
type of protein ubiquitination.
Finally, in mitosis, the mitotic spindle regulates the timing
of spindle assembly factor (SAF) degradation through the
microtubule-mediated protection of SAF ubiquitination [195].6. Phosphorylation regulates APC/C activity
at multiple levels
6.1. APC/C phosphorylation promotes Cdc20 association
and activation
APC/C activity is entirely dependent on its association with
either of the two coactivators Cdc20 and Cdh1, with the
APC/Cbeing activated early inmitosis (afterNEBD—prometa-
phase), remaining active until late G1. Although high mitotic
Cdk activity is required to stimulate the APC/C in mitosis,
the APC/C remains active after mitotic cyclin degradation.
This is due to the reciprocal effects of Cdk phosphorylation on
the activities of Cdc20 and Cdh1 through affecting their affinity
for the APC/C. The association of Cdc20 and Cdh1 with the
APC/C is controlled at the level of both the core APC/C and
coactivator phosphorylation. Cdk-dependent phosphorylation
of core APC/C subunits activates APC/CCdc20 [196–201] bypromoting Cdc20 association [60,199,201–203], whereas Cdh1
binding does not require APC/C phosphorylation [60,198].
Simultaneously, Cdk phosphorylation of Cdh1 completely
blocks its capacity to bind and activate both mitotic and inter-
phase APC/C [32,80,198,204]. As Cdk activity declines at
anaphase due to APC/CCdc20-mediated ubiquitination of
cyclin A and cyclin B, both the APC/C and Cdh1 become
dephosphorylated. This inactivates Cdc20, but allows binding
of Cdh1 to generate APC/CCdh1. Cdh1 is inactivated in late
G1due toS-phase cyclin-dependentphosphorylationandEmi1.
Multiple APC/C subunits are phosphorylated in early
mitosis associated with activation of APC/CCdc20. Apc1 and
Apc3 are hyper-phosphorylated, with Apc3 phosphorylation
readily detected by its retarded mobility on SDS-PAGE. Phos-
phorylation mapping by mass spectrometry of endogenous
APC/C defined multiple phosphosites on Apc1 and Apc3
[201,202,205–207], findings confirmed by in vitro APC/C
phosphorylation analysis using purified Cdk and Plk1 [60].
Two hyper-phosphorylated regions of Apc1 and Apc3 are
the 300s loop of the Apc1 WD40 domain (Apc1300s loop), and
a 300-residue segment in Apc3.
In 2016 three studies provided insights into mechanisms of
activation of vertebrate (human and Xenopus) APC/CCdc20 by
mitotic phosphorylation. These studies revealed that phos-
phorylation-dependent APC/CCdc20 activation primarily
involves phosphorylation of the Apc1300s loop that relieves
an auto-inhibitory segment within the Apc1300s loop, thereby
enabling Cdc20 association [60,202,203]. Introducing phospho-
mimetics into this loop stimulated the ability of Cdc20 to
activate the APC/C [60,202,203] and promoted Cdc20 binding
[202] in the absence of APC/C phosphorylation. In contrast,
mutating phosphosites to Ala ablated Cdc20-dependent
APC/C activation [202,203] and Cdc20 binding [203].
To understand the molecular basis for how phos-
phorylation activates APC/CCdc20, a cryo-EM structure of
phosphorylated APC/CCdc20 was determined [60]. The struc-
ture of phosphorylated APC/CCdc20 is very similar to that of
unphosphorylated APC/CCdh1 (figures 1 and 8). Cdc20
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Figure 9. Control of APC/CCdc20 by phosphorylation. (a) In the unphosphorylated state an auto-inhibitory segment (AI; dark green) within the Apc1300s loop of
Apc1WD40 mimics the Cdc20 C-box motif and binds to the C-box binding site, blocking Cdc20 association. The AI segment is located on the same face of the APC/C as
the hyperphosphorylated Apc3 loop. (b) Zoomed view of the AI segment of Apc1WD40 associated with the C-box binding site of Apc8B. (c) Superposition of the AI
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15interacts with the APC/C through three motifs: the C box to
Apc8B (augmented by the KILR motif [208]), the IR tail to
Apc3A and a region contacting Apc1PC. Relative to Cdh1
the contacts are fewer. Strikingly, EM density corresponding
to phosphorylated regions could not be observed, indicating
that phosphorylated regions of the APC/C do not directly or
indirectly contribute to increasing the affinity of the APC/C
for Cdc20. This implied that APC/C phosphorylation
would remove an inhibitory segment from a Cdc20 binding
site. To explore this possibility, the structures of phosphory-
lated and unphosphorylated apo APC/C were compared.
The two structures were very similar, except that in the
unphosphorylated apo structure, a segment of EM density
occupies the C-box binding site (figure 9). The proximity of
this unassigned EM density to the disordered 300s loop of
the Apc1 WD40 domain (Apc1WD40) suggested that this
segment corresponded to a region of the Apc1300s loop. In a
structure determined with this loop deleted, the C-box bind-
ing site was devoid of EM density [60]. Deletion of the
Apc1300s loop constitutively activated APC/CCdc20 and phos-
phorylation did not further enhance activity [60], a finding
made independently by Kraft et al. [202]. These data convin-
cingly showed that a region within the Apc1300s loop (an
auto-inhibitory (AI) segment) represses Cdc20 stimulation
of unphosphorylated APC/C activity, further supported by
data in Li et al. [110]. Phosphorylation releases this auto-inhi-
bition. In support of the idea that direct phosphorylation of
the AI segment releases this auto-inhibition, substitutingGlu for Cdk phosphorylation sites within the AI segment
constitutively activated APC/CCdc20 [60].
The AI segment includes an Arg-Phe dipeptide, analogous
to the Arg-Tyr motif of the C box. Modelling of the AI seg-
ment into EM density showed that the Arg side chain of the
AI segment mimics the Arg of the Arg-Tyr motif of the C
box, anchoring the AI segment to the C-box binding site
(figure 9c). Mitotic phosphorylation of sites flanking the Arg-
Phe motif would destabilize interactions between the AI seg-
ment and the C-box binding site through steric hindrance and
charge repulsion, leading to the displacement and disordering
of the AI segment and relief of auto-inhibition. These findings
that an auto-inhibitory segment within the Apc1300s loop
blocks Cdc20 activation and that its mitotic phosphorylation
relieves this auto-inhibition are in agreement with biochemical
data [202,203] (figure 10). Fujimitsu and colleagues [203]
showed that Apc1300s bound to the APC/C in an anaphase
extract, whereas the phosphomimetic mutants abolished this
interaction, highlighting how the interaction of Apc1300s with
the APC/C is dependent on its phosphorylation status.
The data of Zhang et al. [60] indicated that the critical deter-
minant of activation of APC/CCdc20 by mitotic
phosphorylationwasdisplacement of theAI segment to relieve
auto-inhibition. However, Apc3 is also highly phosphorylated
in mitosis [201,202,205–207] and Cks stimulates both Cdk-
dependent activation of APC/CCdc20 [197,209] and Apc1 and
Apc3 phosphorylation [60,209], and interacts with Apc3
[25,203, 209,210]. Deletion of the hyperphosphorylated Apc3
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Figure 10. Schematic of control by phosphorylation. In the unphosphorylated state an auto-inhibitory (AI) segment of Apc1WD40 mimics the Cdc20 C-box motif and
binds to the C-box binding site, blocking Cdc20 association. Initial Cdk-dependent phosphorylation of a kinase recruitment loop in Apc3 recruits Cdk-cyclin-Cks to the
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Apc1. From Zhang et al. [60].
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16loop reduced both Apc1 AI segment phosphorylation [60] and
APC/CCdc20 activation [60,203], as well as disrupting
interactions between the APC/C and Cdk–cyclin A–Cks
[60,203]. The phosphorylated Apc3 loop (residues 202–342)
directly binds Cks [203]. Thus a likely explanation for these
findings, and for the lag phase that accompanies APC/C acti-
vation by Cdk1–cyclin B–Cks [197], is that Apc3
phosphorylation recruits Cdk–cyclin–Cks through Cks
[25,209,210] to stimulate Apc1 auto-inhibitory segment phos-
phorylation via a relay mechanism. Cdk–cyclin–Cks
association with the Apc3 loop would allow for a kinetically
more efficient intra-molecular phosphorylation of the Apc1
auto-inhibitory segment that only becomes accessible to Cdk
when transiently displaced from the C-box binding site. Phos-
phorylation of the Apc1300s loop stably displaces the AI
segment from the C-box binding site (figure 10). Intra-molecu-
lar phosphorylation of the Apc1300s loop is associated with
relaxed Cdk specificity and the phosphorylation of non-con-
sensus Cdk sites [60]. Interestingly these sites are not
evolutionarily conserved, suggesting that the exact location
of the phosphorylation sites with Apc1300s is not critical to
their capacity to displace the AI segment.
Cdh1 and Cdc20 bind to common sites on the APC/C, yet
only APC/CCdc20 is activated by phosphorylation [80,60].
The phosphorylation-independent activity of Cdh1 is due to
the increased affinity of Cdh1 for unphosphorylated apo
APC/C, which overcomes the inhibition from the unpho-
sphorylated AI segment. The increased affinity results from
the more extensive contacts formed between the APC/C
and Cdh1 relative to Cdc20. This also explains why the
APC/C inhibitor TAME [211], which interacts with both
the IR tail and C-box binding sites through structural mimi-
cry of the IR tail and C box, is a more potent inhibitor of
APC/CCdc20 than APC/CCdh1 [60].6.2. Cdk phosphorylation of Cdh1 and Cdc20 inhibits
APC/C association
Binding of Cdh1 to the APC/C is negatively regulated by
phosphorylation. Based on the structure of APC/CCdh1.Emi1,
the four phosphorylation sites (Ser40, Thr121, Ser151 and
Ser163 of human Cdh1) that suppress Cdh1 activity
[80,212] can be rationalized (figure 3c). Phosphorylation ofindividual sites only partially suppresses APC/C activity,
whereas phosphorylation of all four sites would destabilize
Cdh1NTD–APC/C interactions through electrostatic repul-
sion and steric clashes. Ser40 is immediately N-terminal to
the C box, whereas the side-chains of Ser151 and Ser163
flank the KLLR motif [80].
Cdk phosphorylation of the Cdc20 NTD also negatively
regulates Cdc20 activation and its binding to the APC/C
[115,213,214]. Cdk2-cyclin A2 phosphorylation of Cdc20 at
interphase is proposed to prevent premature activation of
APC/CCdc20, thereby stabilizing cyclin B1 and promoting
mitotic entry [214]. In mitosis Cdk1-cyclin B1 may contribute
to Cdc20 phosphorylation [214]. The Cdk phosphosites are
close to the N-terminus of the C box (Thr55, Thr59 and Thr70
in human Cdc20, with C box comprising residues Asp77 to
Arg83) [60], thus phosphorylation may block C-box binding
to the Apc8B C-box binding site, reminiscent of Cdh1 inhi-
bition by Cdk phosphorylation [80]. However, it should be
noted that in the APC/CCdc20 structure residues N-terminal
to Ser72 are largely disordered [60], making it unclear mechan-
istically how phosphorylation of Cdc20 N-terminal to the C
box inhibits its activity. Significantly, mutation of Thr55,
Thr59 and Thr70 to Ala produced no cellular phenotype
[214], suggesting that multiple Cdk phosphosites on Cdc20
contribute to its inactivation. These may involve mechanisms
in addition to directly inhibiting its association with the
APC/C. For instance, it is possible that Cdc20 NTD phos-
phorylation affects the structure of free Cdc20, possibly
promoting a closed conformation that cannot bind the APC/
C [215]. PP2A has been suggested as the Cdc20 phosphatase
[115,214] and possibly binds directly to the APC/C mediated
by PP2AB56 [216]. A recent study in Caenorhabditis elegans
showed that kinetochore-associated PP1 also contributes to
dephosphorylation of Cdc20 Cdk phosphosites (with Thr32,
equivalent to human Thr70, being a key site responsible for
the control of C. elegans Cdc20 by phosphorylation) through
a mechanism by which Cdc20 is recruited to kinetochore by
the ABBA motif of Bub1 [217]. Thus, depending on the status
of their microtubule attachment, kinetochores either inactivate
(via the SAC) or activate (via Cdc20 dephosphorylation) APC/
CCdc20. This explains the paradox that the checkpoint proteins
Bub1/Bub3 promote anaphase onset independently of the
checkpoint [218,219]. While Ala substitution of Cdk sites
within the NTDofC. elegansCdc20 accelerated normalmitosis,
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17this mutant retained the ability to significantly delay mitosis in
the presence of unattached kinetochores [217], indicating that
Cdk phosphorylation of Cdc20 does not contribute to the SAC.
Plk1 (mediated through a scaffolding role of Bub1) phos-
phorylation of human Cdc20 on Ser92 impaired the assembly
of polyubiquitin chains in vitro, mainly through inhibition of
Ube2S [220] by preventing the association of Ube2S to the
APC/C [220,221]. Analysis of the APC/CCdc20 structure
indicates that Ser92 is in contact with Apc8B [60], remote
from the Ube2S binding site [112]. Thus themolecularmechan-
ism by which Ser92 phosphorylation inhibits Ube2S is not
currently clear. Ser92 phosphorylation does not affect the
MCC-mediated inhibition of APC/CCdc20, revealing that
Bub1-Plk1 directly inhibits APC/CCdc20 through a mechanism
that is independent of the MCC [220]. The inhibitory
phosphorylation on Cdc20 is removed by PP2AB56, a
kinetochore-bound phosphatase [220,221] and PP1 [217].
6.3. Substrate phosphorylation can regulate association
with the APC/C
Direct phosphorylation of substrates provides a third level of
APC/C control by protein phosphorylation, discussed above.7. Emi1 inhibits APC/CCdh1
In vertebrates, Emi1 functions as an antagonist of APC/CCdh1
during G2 [42,43]. Four functional elements of Emi1 mediate
APC/CCdh1 inhibition [80,107,172,222]. Similar to the MCC,
Emi1 blocks D-box recognition by APC/C–coactivator com-
plexes and also antagonizes the two E2s UbcH10 and Ube2S.
A D-boxmotif that occludes substrate recognition is connected
through a linker to a zinc-binding region (ZBR) (Emi1ZBR)
that interferes with UbcH10-dependent APC/C activity
[107,172,222] (figure 1a). A C-terminal LRRL sequence
(LR tail: Emi1LR), identical to the LRRL motif required for
Ube2S-dependent synthesis of polyubiquitin chains on
APC/C substrates [150,151] and its association with the APC/
C [86,154,172], antagonizes Ube2S [107,172] by interacting
with the Ube2S LRRL-tail binding site on Apc4 [80].8. Reciprocal regulation of the spindle
assembly checkpoint and APC/CCdc20
To ensure the fidelity of the inheritance of genetic information,
the cell has evolved cell cycle checkpoints that control pro-
gression through cell cycle transitions that are dependent on
the successful completion of a preceding event. The spindle
assembly checkpoint (SAC), also known as the mitotic
checkpoint and kinetochore checkpoint, coordinates sister
chromatid segregation at themetaphase to anaphase transition
with the correct bipolar attachment of sister chromatids to
the mitotic spindle [40,41]. The SAC is exerted by the mitotic
checkpoint complex (MCC), amulti-protein complex that func-
tions to repress APC/C activity. Generation of the MCC is
catalysed by unattached kinetochores whose structural and
biochemical properties are becoming well defined [223,224].
MCC assembly occurs on the outer regions of the kinetochore,
specifically the KMN (Knl1-Mis12-Ndc80) network which
functions as a recruiting site for multiple checkpoint com-
ponents. Key among these are the Mad and Bub proteins,identified over 25 years ago in genetic screens for SAC com-
ponents [225,226]. A checkpoint cascade results in the
assembly of a molecular scaffold that catalyses conversion of
O-Mad2 (open state of Mad2) to C-Mad2 (closed state of
Mad2), in a process that requires the kinetochore-associated
C-Mad2. In the template-assisted mechanism [227], the kineto-
chore-associated C-Mad2, bound to the kinetochore through
Mad1, interacts with O-Mad2 to promote its conversion to
C-Mad2, a reaction catalysed by Mps1 [224,228]. C-Mad2 cap-
tures the N-terminus of Cdc20 and the resultant C-Mad2-
Cdc20 binary complex interacts rapidly with BubR1-Bub3 to
generate the tetrameric MCC (C-Mad2-Cdc20-BubR1-Bub3)
[229]. The MCC is a potent APC/C inhibitor, some 3000-fold
more potent than Mad2 alone [229]. The target of the MCC is
APC/CCdc20 [230].
The structural mechanisms underlying how the APC/C
and the MCC are reciprocally regulated in the context of the
SAC were defined from cryo-EM reconstructions of APC/
CCdc20 in complex with the MCC (APC/CMCC) [92,93]. These
studies explained how the MCC blocks D-box- and KEN-
box-dependent substrates from interacting with APC/CCdc20,
and also surprisingly revealed how the MCC interferes with
the initiating E2, UbcH10.
Overall structure of the APC/CMCC. Recombinant reconsti-
tuted APC/CMCC comprises two Cdc20 subunits, consistent
with the notion that the MCC interacts with APC/CCdc20
[92,93,230–232]. Importantly, the overall structure is essentially
identical to the endogenous APC/CMCC isolated from check-
point-arrested HeLa cells (at much lower resolution) [105].
This validated the notion that the physiologically relevant
form of APC/CMCC includes two Cdc20 molecules (termed
Cdc20APC/C and Cdc20MCC for the Cdc20 subunits of APC/
CCdc20 and MCC, respectively) [230,231]. In the APC/CMCC
reconstruction, a large density element termed the MCC-
Cdc20 module (MCC and Cdc20APC/C) occupies the central
APC/C cavity extending from the front side of the platform
domain. The core MCC elements comprising Cdc20MCC, the
TPR domain of BubR1 andC-Mad2 resemble their counterparts
in the free S. pombeMCC structure [69]. Although present in the
reconstituted complex, no EM density was visible for BubR1’s
C-terminal regions (that includes a pseudo-kinase domain)
and its associated Bub3 subunit. Mad2 adopts the closed con-
formation with its safety belt entrapping the N-terminal KILR
motif of Cdc20.
The MCC docks into the central cavity of the APC/C
contacting Cdc20APC/C and Apc2WHB (figure 11). Apc2WHB
rigidifies and repositions (relative to APC/CCdh1-UbcH10
[111]) to engage BubR1. Contacts between the two Cdc20 mol-
ecules aremainlymediated by BubR1 that intertwines between
them. Through extensive contacts between BubR1 and the two
Cdc20 molecules, BubR1 obstructs degron dependent binding
to both coactivator subunits. This is achieved because BubR1
incorporates two copies of both the D-box (D1, D2) and
KEN-box motifs (K1, K2) and three copies of the ABBA motif
(A1–A3) (figure 11b) [92,93,120,121,233]. Six of these motifs
interact with the six degron recognition sites on both coactiva-
tors thereby blocking substrate recognition. Apart from the
N-terminal KEN motif (K1) that is present within a structured
regionN-terminal to the TPR domain (within a helix-turn-helix
motif) five of the pseudo-substrate degronmotifs are present in
a long disordered segment, C-terminal to the TPR domain
(figure 11b). This allows BubR1 to intertwine around
Cdc20APC/C and then fold back to contact the A2 and D2
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18sites on Cdc20MCC, forming a lariat-like structure
(figure 11a,c,d ). The contacts between D1, A1 and K2 of
BubR1 and Cdc20APC/C explain why these three motifs are
critical to APC/C–MCC interactions and function to sustain
the checkpoint response [121,208,233–236]. In contrast, the
contacts between A2 and D2 with Cdc20MCC are not as critical
for MCC stability and APC/C–MCC interactions, hence the
more modest effects of disrupting the checkpoint when these
motifs are deleted. D1, A1, K2, A2 occur in an evolutionarily
conserved cassette, suggesting the mechanism for inhibiting
the APC/C is conserved in all major eukaryotic super groups
over one billion years of evolution [233,236]. In addition to
directly blocking degron recognition sites on the Cdc20APC/C
WD40 domain, MCC interactions with APC/CCdc20 cause a
rotation and translation of Cdc20APC/C away from Apc10, dis-
rupting the D-box co-receptor, with a portion of A1 now
contacting the D-box binding surface of Apc10 [92].
Having effectively shut down degron recognition
by Cdc20APC/C, (although not necessarily Cdc20MCC), the
MCC also represses APC/C’s E3 ligase catalytic activity. In the
majority of APC/CMCC molecules (in the Alfieri et al. study
[92]) APC/CMCC adopts a closed conformation (APC/CMCC-
closed) whereby MCC, through the TPR domain of BubR1, con-
tacts Apc2WHB (figures 11 and 12a). This obstructs the UbcH10
binding site on the catalytic module. APC/CMCC-closed is
accompanied by an order-to-disorder transition of the Apc15
N-terminal helix (Apc15NTH) due to the binding of Cdc20MCC
to the platform region. This induces an upward movement of
the Apc4 helix bundle domain (Apc4HBD) and its adjacent
Apc5 N-terminal domain (Apc5NTD), disrupting their contacts
to Apc15NTH (figure 12a,b). Interestingly, in a small populationof APC/CMCC, the molecule adopts an open state
(APC/CMCC-open) whereby MCC has rotated away from the
catalytic module exposing the UbcH10 binding site on
Apc2WHB (figure 12b). This large repositioning of the MCC is
dependent on the disorder-to-order transition of Apc15NTH.
On transition from APC/CMCC-closed to APC/CMCC-open,
Apc15NTH rebinds to Apc5NTD. This induces a downward
rotationofApc5NTD anddownward translationofApc4HBD, dis-
placing the Cdc20MCC binding site on Apc4HBD by 10 A˚. Loss of
the Cdc20MCC-binding interface on the platform releases the
MCC to rotate away from the catalytic site of the APC/C
(figure 12a,b).
In the study of Schulman and colleagues the open APC/
CMCC conformation predominates [93]. Whatever the cause of
difference in the open-closed ratio between the two studies
(possibly due to differences in APC/CMCC reconstitution
approaches), open APC/CMCC is associated with an ordered
conformation of Apc15NTH, suggesting that the order-to-
disorder transition of Apc15NTH influences the open–closed
transition. In support of this notion, deletion of Apc15 locks
all APC/CMCC molecules into the closed state, consequently
repressing Cdc20MCC auto-ubiquitination [92,93].
The open APC/CMCC conformation would suggest that
UbcH10 has the capacity to interact with the APC/CMCC,
a proposal indeed verified by structures of APC/CMCC–
UbcH10 complexes (figure 12c) [92,93]. In these complexes,
UbcH10 is bound to the Apc2WHB-Apc11RING catalytic
module, as in previous APC/C–UbcH10 complexes [80,111].
The MCC adopts the open conformation with Apc15NTH
ordered.Strikingly, theC-terminusofCdc20MCCengages thecat-
alytic site of UbcH10 with two Lys residues of Cdc20MCC (K485
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19and K490) accessible to the catalytic site, andwhich in the recon-
stituted APC/CMCC are auto-ubiquitinated in an Apc15-
and UbcH10-dependent process [92]. Destabilizing closed
APC/CMCC, either through disrupting the Apc2WHB interface
on BubR1 or by deleting the IR tail of Cdc20MCC (which
binds Apc8A in closed APC/CMCC), promotes Cdc20MCC
auto-ubiquitination, even in the absence of Apc15 [92,93].
These structural and biochemical data show that Cdc20MCC
is auto-ubiquitinated by UbcH10 in the context of the open
APC/CMCC conformation. This requires Apc15 and thus
explains how Apc15 deletion suppresses Cdc20 auto-
ubiquitination in a SAC-dependent manner. Because Apc15
deletion blocks progression into anaphase after release from
the SAC [59,90,91], it suggests that one mechanism by which
the SAC is inactivated is through Cdc20MCC auto-ubiquitina-
tion leading to disassembly of APC/CMCC, generating active
APC/CCdc20 (figure 13). SAC-mediated Cdc20 proteolysis is
dependent on the APC/C, Mad2 and BubR1 [94,95,237–240],
suggesting that Cdc20MCC ubiquitination occurs in the context
of APC/CMCC. Consistentwith release frommitotic arrest, con-
comitantwithCdc20 degradation, is the requirement for Apc15
[59,90,91] andUbe2S thatwould cooperatewithUbcH10 toubi-
quitinateCdc20MCC, to regulate inactivation of the SAC [173]. In
vitro Mad2, Cdc20 and BubR1 are released from APC/CMCC
following UbcH10-catalysed ubiquitination [91,94,241]. The
MCC disassembly products are mainly free BubR1 and Mad2associated with polyubiquitinated Cdc20. The release of MCC
subunits by APC/CMCC was impaired by a lysine free version
of Cdc20 [241]. The situation may differ in vivo because the
Cdc20K485R/K490R mutant did not prevent MCC release from
APC/CMCC after a mitotic arrest [59]. However, it is possible
that in the K485R/K490R mutant alternative lysines in
Cdc20MCC could be ubiquitinated in the context of the APC/
CMCC, as Schulman and colleagues observed [93].
To ensure efficient MCC release at anaphase onset,
additional MCC subunits might also be ubiquitinated.
A good candidate is BubR1 that is ubiquitinated in the context
of purified APC/CMCC and UbcH10 [241]. Supporting the
idea that MCC ubiquitination is required for its release from
APC/CMCC, depletion of either Apc11 or UbcH10 decreased
the amount of MCC dissociated from APC/CMCC after a mito-
tic arrest [59]. In addition, APC/C regulation of BubR1
homeostasis is essential for correct mitotic timing [242,243].
In APC/CMCC-open the lysine-containing region of BubR1 prox-
imal to D1 is close to the catalytic module of the APC/C,
consistent with a model whereby BubR1 is auto-ubiquitinated
in the context of APC/CMCC [92] (figures 12c and 13).
The architecture and composition of APC/CMCC complexes
are conserved in S. pombe. However in fission yeast, although
Apc15 is also required for Cdc20MCC auto-ubiquitination
[232], it additionally functions to exert a checkpoint arrest by
stabilizing APC/C–MCC interactions [232,235].
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20Cdc20MCC auto-ubiquitination is an important event
because it contributes to the reciprocal regulation of the APC/
C and MCC (figure 13). MCC binding to the APC/C represses
APC/C activity. However, in a competing process, dependent
on the open conformation of APC/CMCC, APC/CMCC is disas-
sembled due to Cdc20MCC auto-ubiquitination [94] and APC/
CCdc20 is reactivated. As long as the SAC is active and new
MCC is generated, APC/CMCC will reform to suppress APC/
C activity. When the SAC is turned off, MCC assembly at the
kinetochore stops, and Cdc20MCC auto-ubiquitination allows
the spontaneous activation of the APC/C through APC/
CMCC disassembly, thereby driving cells into anaphase. This
model is consistent with the idea that correctly attached
kinetochores do not need to generate and transmit a signal to
APC/CMCC to activate the APC/C to initiate chromosome
segregation. Only unattached kinetochores signal to regulate
the APC/C during the SAC.
In vivo, the ratio of the open–closed state of APC/CMCC, as
well as the factors that influence the open–closed transition
and thus Cdc20MCC auto-ubiquitination, are unknown. The
SAC arrest protein p31Comet, that promotes Cdc20MCC auto-
ubiquitination [94,244] (although not in vitro [241]), and/or
Cdc20 phosphorylation are candidates. Furthermore, USP44
catalyses Cdc20MCC deubiquitination, thereby antagonizing
Cdc20MCC ubiquitination to stabilize the APC/CMCC, thus sus-
taining the SAC [95]. Moreover, a ubiquitination-independent
pathway functions to disassemble the free MCC through
the activities of the AAAþ ATPase TRIP13 [245–247], in con-
junction with the SAC antagonist p31Comet [248], a C-Mad2
binding protein [249]. p31Comet extracts Mad2 from theMCC [250] and targets C-Mad2-Cdc20 to TRIP13 [251], and
competes with BubR1 for C-Mad2 [252].
Errors in controlling accurate chromosome segregation due
to defects in the SAC underlie aneuploidy and chromosome
instability (CIN), and cause tumour heterogeneity and drug
resistance [253]. However, extreme CIN correlates with
improved cancer outcome, possibly because karyotypic diver-
sity is required to adapt to selection pressures. A study from
Swanton and colleagues found that partial APC/C dys-
function caused by somatic mutations in cancer cell lines
lengthened mitosis, suppressed pharmacologically induced
chromosome segregation errors and reduced naturally
occurring lagging chromosomes. APC/C impairment caused
adaptation to Mps1 inhibitors, suggesting a likely resistance
mechanism to therapies targeting the SAC [254].9. Spatial regulation of the APC/C
Specifics of the intracellular location and spatial control of the
APC/C are relatively little understood [255]. The APC/C is
localized to centrosomes through Emi1–NUMA complexes
[256], the recently identified KIAA1430 protein [257] and to
the chromosomes through interactions mediated by the
Ska3 complex [258,259].10. Conclusion and perspectives
An enduring question asked about the APC/C is why is it so
large? The simplest response must be that its size reflects its
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21central role in coordinating critical transitions during the cell
cycle. This requires control at multiple levels (through inter-
changeable coactivator subunits, phosphorylation, the SAC
and Emi1, often exerted through allosteric conformational
changes of the APC/C), and the capacity of the APC/C to
change its substrate specificity during different phases of
the cell cycle, transition through which is controlled by the
APC/C. Thus, the APC/C possesses intrinsic self-
control mechanisms. This is probably best exemplified by
the auto-ubiquitination of Cdc20MCC that enables spon-
taneous activation of the APC/C at anaphase only when all
chromosomes have achieved correct bipolar attachment to
the mitotic spindle. The large size of the APC/C is contribu-
ted by the seven scaffolding proteins, four of which form
structurally related homo-dimers, which stack in parallel to
create the pseudo-dyad symmetric TPR lobe. This TPR lobe,
together with Apc1, Apc4 and Apc5 of the platform, assem-
bles the scaffold to juxtaposition the catalytic and substrate
recognition modules. The structural symmetry of the TPR
lobe generates multiple structurally related binding sites
that engage the C box and IR tail of coactivators and IR tail
of Apc10. The structural equivalence of the C-box binding
site of Apc8B and the IR-tail binding sites of Apc3 is illus-
trated by the engagement of the Cdc20MCC IR tail with the
C-box binding site of Apc8A [92,93]. The APC/C is a distant
ancestor of the large CRL family of E3 ligases. Both share a
conserved catalytic module of RING and cullin subunits.
How the APC/C evolved from the simpler CRLs is not
clear because there are no obvious intermediate complexes.
All the large scaffolding subunits comprise multiple repeat
motif domains. TPR and WD40 repeat motifs are ubiquitous
in proteins involved in protein–protein interactions, and it is
intriguing that the only other known instances of the PC
repeat domain are the Rpn1 and Rpn2 subunits of the 19S
regulatory particle of the proteasome [85].Of interest is the realization that the APC/C functions by
engaging coactivators, substrates and inhibitors through rec-
ognition of short linear sequence motifs, for example
degrons, C box, IR tail and MR tail [120]. Conformational
variability of small domains attached to the APC/C scaffold
through flexible linkers (Apc2WHB, Apc11RING and the WD40
domains of coactivators) has important implications for
mediating catalysis and regulation.
Despite the huge progress in understanding the function
and mechanism of the APC/C during the two decades since
its discovery, much needs to be explored. We still have little
molecular understanding of how the APC/C selects different
substrates during the cell cycle. This will require cryo-EM
structures of different states of the APC/C in complex with
full-length intact substrates, in addition to more quantitative
determinations of the affinities of different APC/C complexes
for their cognate substrates. To what extent APC/C–substrate
affinities compared with the catalytic efficiency of lysine ubi-
quitination (determined by substrate–lysine proximity to the
E2 catalytic site and the competing rates of deubiquitination)
controls the rate of substrate degradation is unclear. The level
to which the intracellular location of APC/C complexes
controls their various functions and how this is subject to
cell-cycle regulation are also still largely unexplored.Data accessibility. This article has no additional data.
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